Efficacy Of Macular Photocoagulation When Given In The Early Or Late Period After Single Intravitreal Bevacizumab Injection In Terms Of Central Foveal Thickness Change And Visual Acuity Gain
DOI:
https://doi.org/10.48165/ijabms.2021.23122%20Keywords:
bevacizumab, laser photocoagulation, diabetic retinopathyAbstract
AIM: To find out the efficacy of macular photocoagulation when given in the early or late period after single intravitreal bevacizumab injection in terms of central foveal thickness change and visual acuity gain.
METHODS:40 patient eyes were studied and they were divided into groups based on sex, age, hba1c levels, severity of disease and treatment received over the period of 6months.
RESULT: patients receiving deferred macular photocoagulation after a single intravitreal injection of bevacizumab had better outcomes regarding reduction of central foveal thickness and improvement in visual acuity at the end of 6-month observation period compared to those patients receiving prompt macular photocoagulation.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Aaska Sapan Shah, Naimish Haribhai Mahaliya, Sapan Snehalbhai shah , Jitendrabhai Joshi
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
